Please login to the form below

Not currently logged in

BMS claims 80% market share for Opdivo in US

Bristol-Myers Squibb (BMS) buildingNew indications and label updates boost the cancer immunotherapy’s market position

Respiratory return helps GSK to solid first quarter

GSK - logo on buildingSeretide decline offset by gains for new-generation products Anoro, Breo and Nucala

Lilly's psoriasis drug Taltz cleared in Europe

Eli Lilly HQClinicians suggest the IL-17 inhibitor has “best-in-class data”

Social media win for Boehringer at PM Society Digital Awards

Boehringer Ingelheim PM Society Digital Awards 2016 social mediaSees off competition from AbbVie, Bayer, Novartis and Pfizer

Are you experienced?

Identifying and exceeding customer expectations remains a work-in-progress for pharma

The new EU clinical trial lay summaries

New regulations will require both a trial summary and a lay person’s summary

Apple launches CareKit mHealth developer software

Makes its debut alongside apps for reproductive health, diabetes and depression

Apple CareKit iPhone app

Merck appoints ex-Pfizer exec as global head of oncology

Maya Martinez-Davis succeeds Andrew Schiermeier in the role

Quintiles promotes Robert Taylor

He becomes head of Europe, commercial solutions

First online ADHD treatment test launched in the US

Qbtech brings its QbCheck assessment to market after winning FDA approval

QbCheck Qbtech ADHD online test

Stories that can save lives

“Sometimes reality is too complex. Stories give it form.”

Science doesn’t sell

Healthcare communications aren’t lacking in clinical data - what they need is a dose of advertising ideals

Featured jobs

Subscribe to our email news alerts


Add my company
Seven Stones

Seven Stones is a creative, independent healthcare communications agency focused on delivering what we call our 'total health' proposition -...

Latest intelligence

EY Life Sciences Sector Update
Asia-Pacific and Japan...
A roadmap to strategic drug pricing
The current unit-based pricing model for drugs is too one-dimensional for the market's present needs. Pharma firms must identify products that will benefit from innovative pricing models, and then forge...
The growing necessity for pharma to become a true health delivery partner of the NHS